Global Non-invasive Prenatal Testing (NIPT) Market, Forecast to 2025 - ResearchAndMarkets.com

DUBLIN--()--The "Global Non-invasive Prenatal Testing (NIPT) Market By Application (Trisomy (Down syndrome, Edwards syndrome, Patau syndrome), Turner syndrome, Rh Blood type and Others), By Product, By Technology, By End User, By Region, Forecast & Opportunities, 2025" report has been added to ResearchAndMarkets.com's offering.

The Global Non-Invasive Prenatal Testing (NIPT) Market is expected to witness a robust growth during the forecast period.

Increasing genetic disorders in pre-borne children and growing population are the major factors for the growth of the market. Additionally, rise in maternal age and technology advancement have also boosted the demand of NIPT solutions as parents wants to ensure that their baby is free from all disorders and earlier diagnosis assist in that. However, high maintenance and lack of competent professionals are major factors restraining the growth of the market across the globe.

The Global Non-Invasive Prenatal Testing (NIPT) Market is segmented based on application, product, technology, end-user and region. The application segment is further segmented into trisomy, turner syndrome, Rh blood type and others, out of which trisomy held the dominant share in 2019 due to the increasing prevalence of Down's syndrome, Edward's syndrome and Patau syndromes in unborn children.

In terms of regional analysis, North America led the market in 2019. The factors responsible for the dominance of North America include heavy funding by the government and presence of the leading market players in the region. On the other hand, Asia-Pacific is anticipated to grow at the fastest rate in the coming years due to increasing awareness about prenatal testing among population.

Leading players in the Global Non-Invasive Prenatal Testing (NIPT) Market include Roche, Integrated Genetics, Natera, BGI Genomics, Illumina, Invitae, Genesis Genomics, PerkinElmer, Eurofins Scientific, Thermo Fisher Scientific, Agilent Technologies, Yourgene Health, Berry Genomics, Igenomix, Quest Diagnostics, Asper Biogene, Myriad Genetics, Progenity, Fasteris, Bionet Corp, etc. In order to maintain their position in the market and to generate large revenues, leading players tend to adopt various organic and inorganic strategies like mergers and acquisitions.

Years considered for this report:

  • Historical Years: 2015-2018
  • Base Year: 2019
  • Estimated Year: 2020
  • Forecast Period: 2021-2025

Objective of the Study

  • To analyze and forecast the market size of the Global Non-Invasive Prenatal Testing (NIPT) Market.
  • To classify and forecast the Global Non-Invasive Prenatal Testing (NIPT) Market based on application, product, technology, end-user and region and company.
  • To identify drivers and challenges for the Global Non-Invasive Prenatal Testing (NIPT) Market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in the Global Non-Invasive Prenatal Testing (NIPT) Market.
  • To conduct pricing analysis for the Global Non-Invasive Prenatal Testing (NIPT) Market.
  • To identify and analyze the profile of leading players operating in the Global Non-Invasive Prenatal Testing (NIPT) Market.

Key Topics Covered

1. Product Overview

2. Research Methodology

3. Impact of COVID-19 on Global Non-Invasive Prenatal Testing (NIPT) Market

4. Executive Summary

5. Global Non-Invasive Prenatal Testing (NIPT) Market Outlook

5.1. Market Size & Forecast

5.1.1. By Value & Volume

5.2. Market Share & Forecast

5.2.1. By Application (Trisomy (Down Syndrome, Edwards Syndrome, Patau Syndrome), Turner Syndrome, Rh Blood Type and Others)

5.2.2. By Products (Instruments, Kits and Assay)

5.2.3. By Technology (Cell Free Fetal DNA Technology, Massively Parallel Sequencing, Target Capture Sequences Technology and Others)

5.2.4. By End-user (Hospitals and Diagnostic Laboratory)

5.2.5. By Company (2019)

5.2.6. By Region

5.3. Market Attractiveness Index

6. Asia-Pacific Non-Invasive Prenatal Testing (NIPT) Market Outlook

7. Europe Non-Invasive Prenatal Testing (NIPT) Market Outlook

8. North America Non-Invasive Prenatal Testing (NIPT) Market Outlook

9. South America Non-Invasive Prenatal Testing (NIPT) Market Outlook

10. Middle East & Africa Non-Invasive Prenatal Testing (NIPT) Market Outlook

11. Market Dynamics

11.1. Drivers

11.2. Challenges

12. Market Trends & Developments

13. Competitive Landscape

13.1. Competition Outlook

13.2. Players Profiled (Leading Companies)

13.2.1. Roche

13.2.2. Integrated Genetics

13.2.3. Natera

13.2.4. BGI Genomics

13.2.5. Illumina

13.2.6. Invitae

13.2.7. Genesis Genomics

13.2.8. PerkinElmer

13.2.9. Eurofins Scientific

13.2.10. Thermo Fisher Scientific

13.2.11. Agilent Technologies

13.2.12. Yourgene Health

13.2.13. Berry Genomics

13.2.14. iGenomix

13.2.15. Quest Diagnostics

13.2.16. Asper Biogene

13.2.17. Myriad Genetics

13.2.18. Progenity

13.2.19. Fasteris

13.2.20. Bionet Corp.

14. Strategic Recommendations

For more information about this report visit https://www.researchandmarkets.com/r/2vkwcv

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900